Table 2.
BEV, % (95% CI) | BEV/pRDR, % (95% CI) | P value | Hazard ratio | |
---|---|---|---|---|
6-mo OS | 69 (54–81) | 97 (80–100) | .0030 | 10.83 |
12-mo OS | 34 (20–48) | 73 (53–86) | .0008 | 3.48 |
18-mo OS | 24 (12–38) | 42 (24–59) | .0013 | 2.18 |
24-mo OS | 11 (3–23) | 19 (7–35) | .0016 | 1.85 |
6-mo PFS | 36 (22–50) | 82 (63–92) | <.0001 | 5.68 |
12-mo PFS | 16 (6–29) | 56 (36–72) | <.0001 | 3.84 |
18-mo PFS | 9 (2–21) | 22 (9–39) | .0002 | 2.58 |
24-mo PFS | 3 (0–13) | 15 (5–31) | .0002 | 2.51 |
Abbreviations: CI = confidence interval; OS = overall survival; PFS = progression-free survival; pRDR = pulsed reduced dose rate radiation therapy.
Percent OS and PFS at 6, 12, 18, and 24 months were significantly better in the BEV/pRDR group compared to the BEV group.